Armon C: Amyotrophic lateral sclerosis. Neuroepidemiology From principles to practice. Edited by: Nelson LM, Tanner CM, Van Den Eeden SK, McGuire VM. 2004, New York: Oxford University Press, 162-187.
Google Scholar
Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ: Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers -- smoking as a cause of oxidative damage. N Engl J Med. 1995, 332 (18): 1198-1203. 10.1056/NEJM199505043321804.
Article
CAS
PubMed
Google Scholar
Chiba M, Masironi R: Toxic and trace elements in tobacco and tobacco smoke. Bulletin of the World Health Organization. 1992, 70 (2): 269-275.
CAS
PubMed
PubMed Central
Google Scholar
Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EFM: Systemic effects of smoking. Chest. 2007, 131 (5): 1557-1566. 10.1378/chest.06-2179.
Article
CAS
PubMed
Google Scholar
Weisskopf MG, Ascherio A: Cigarettes and amyotrophic lateral sclerosis: only smoke or also fire?. Ann Neurol. 2009, 65 (4): 361-362. 10.1002/ana.21700.
Article
PubMed
Google Scholar
Armon C: An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003, 22: 217-228. 10.1159/000070562.
Article
PubMed
Google Scholar
Alonso A, Logroscino G, Hernán MA: Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatr. 2010, 163 (11): 1021-30.
Google Scholar
Kamel F, Umbach DM, Stallone L, Richards M, Hu H, Sandler DP: Association of lead exposure with survival in amyotrophic lateral sclerosis. Environ Health Perspect. 2008, 116: 943-947. 10.1289/ehp.11193.
Article
CAS
PubMed
PubMed Central
Google Scholar
del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, van Belle G: Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003, 60: 813-819. 10.1001/archneur.60.6.813.
Article
CAS
PubMed
Google Scholar
Paillisse C, Lacomblez L, Dib M, Bensimon G, Garcia-Acosta S, Meininger V: Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005, 6: 37-44. 10.1080/14660820510027035.
Article
CAS
PubMed
Google Scholar
Wood L, Martinez C: The General Practice Research Database. Role in pharmacovigilance. Drug Safety. 2004, 27 (12): 871-881. 10.2165/00002018-200427120-00004.
Article
PubMed
Google Scholar
Lawson DH, Sherman V, Hollowell J: The General Practice Research Database. Scientific and Ethical Advisory Group. QJM. 1998, 91 (6): 445-452. 10.1093/qjmed/91.6.445.
Article
CAS
PubMed
Google Scholar
Jick H, Jick SS, Derby LE: Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991, 302: 766-768. 10.1136/bmj.302.6779.766.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jick H, Terris BZ, Derby LE, Jick SS: Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf. 1992, 1: 347-349. 10.1002/pds.2630010607.
Article
Google Scholar
Jick SS, Kaye JA, Vasilakis-Scaramozza C, García Rodríguez LA, Ruigomez A, Meier CB, Schlienger RG, Black C, Jick H: Validity of the General Practice Research Database. Pharmacotherapy. 2003, 23 (5): 686-689. 10.1592/phco.23.5.686.32205.
Article
PubMed
Google Scholar
García Rodríguez LA, Pérez Gutthann S: Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998, 45 (5): 419-425. 10.1046/j.1365-2125.1998.00701.x.
Article
PubMed
PubMed Central
Google Scholar
Alonso A, Logroscino G, Jick SS, Hernán MA: Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009, 16: 745-751. 10.1111/j.1468-1331.2009.02586.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hernández-Díaz S, García Rodríguez LA: Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer. 2007, 120: 1565-1572. 10.1002/ijc.22514.
Article
PubMed
Google Scholar
Zhang X, Loberiza FR, Klein JP, Zhang M-J: A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput Methods Programs Biomed. 2007, 88: 95-101. 10.1016/j.cmpb.2007.07.010.
Article
PubMed
Google Scholar
Hernán MA, Alonso A, Logroscino G: Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology. 2008, 19 (3): 448-450. 10.1097/EDE.0b013e31816bbe14.
Article
PubMed
Google Scholar
Hernán MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ: A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol. 2002, 52 (3): 276-284. 10.1002/ana.10277.
Article
PubMed
Google Scholar
Kamel F, Umbach DM, Munsat TL, Shefner JM, Sandler DP: Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology. 1999, 18: 194-202. 10.1159/000026211.
Article
CAS
PubMed
Google Scholar
Nelson LM, McGuire V, Longstreth WT, Matkin C: Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000, 151 (2): 156-163.
Article
CAS
PubMed
Google Scholar
Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, Kaaks R, Allen NE, Roddam AW, et al: Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol. 2009, 65: 378-385. 10.1002/ana.21653.
Article
PubMed
Google Scholar
Fang F, Bellocco R, Hernán MA, Ye W: Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis - a prospective cohort study. Neuroepidemiology. 2006, 27 (4): 217-221. 10.1159/000096956.
Article
PubMed
Google Scholar
Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A: Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. 2004, 160 (1): 26-33. 10.1093/aje/kwh179.
Article
CAS
PubMed
Google Scholar
Rothstein JD: Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009, 65 (suppl): S3-S9. 10.1002/ana.21543.
Article
CAS
PubMed
Google Scholar
Hoffmann D, Hoffmann I, El-Bayoumy K: The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol. 2001, 14 (7): 767-790. 10.1021/tx000260u.
Article
CAS
PubMed
Google Scholar
Kamel F, Umbach DM, Hu H, Munsat TL, Shefner JM, Taylor JA, Sandler DP: Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis. 2005, 2 (3-4): 195-201. 10.1159/000089625.
Article
CAS
PubMed
Google Scholar
Weisskopf MG, Morozova N, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ, Ascherio A: Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr. 2009, 80 (5): 558-561. 10.1136/jnnp.2008.156976.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gan W, Man SF, Postma D, Camp P, Sin D: Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2006, 7 (1): 52-10.1186/1465-9921-7-52.
Article
PubMed
PubMed Central
Google Scholar
Sin DD, Cohen SB-Z, Day A, Coxson H, Paré PD: Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc Am Thorac Soc. 2007, 4: 671-674. 10.1513/pats.200706-082SD.
Article
CAS
PubMed
Google Scholar
Vestergaard P: Smoking and thyroid disorders - a meta-analysis. Eur J Endocrinol. 2002, 146: 153-161. 10.1530/eje.0.1460153.
Article
CAS
PubMed
Google Scholar
Chio A, Ciccone G, Calvo A, Vercellino M, Di Vito N, Ghiglione P, Mutani R, the Piemonte and Valle d'Aosta Register for ALS: Validity of hospital morbidity records for amyotrophic lateral sclerosis. A population-based study. J Clin Epidemiol. 2002, 55: 723-727. 10.1016/S0895-4356(02)00409-2.
Article
PubMed
Google Scholar